GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Catalent Inc (NYSE:CTLT) » Definitions » Price-to-Operating-Cash-Flow

CTLT (Catalent) Price-to-Operating-Cash-Flow : 28.88 (As of Jun. 27, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Catalent Price-to-Operating-Cash-Flow?

As of today (2025-06-27), Catalent's share price is $63.48. Catalent's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was $2.20. Hence, Catalent's Price-to-Operating-Cash-Flow Ratio for today is 28.88.

The historical rank and industry rank for Catalent's Price-to-Operating-Cash-Flow or its related term are showing as below:

CTLT' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 11.27   Med: 27.74   Max: 93.74
Current: 28.88

During the past 13 years, Catalent's highest Price-to-Operating-Cash-Flow Ratio was 93.74. The lowest was 11.27. And the median was 27.74.

CTLT's Price-to-Operating-Cash-Flow is not ranked
in the Drug Manufacturers industry.
Industry Median: 17.41 vs CTLT: 28.88

Catalent's Cash Flow from Operations per share for the three months ended in Sep. 2024 was $0.34. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was $2.20.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Catalent was 45.90% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -16.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -7.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 1.90% per year.

During the past 13 years, Catalent's highest 3-Year average Operating Cash Flow per Share Growth Rate was 25.70% per year. The lowest was -21.50% per year. And the median was 11.20% per year.


Catalent Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Catalent's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Catalent Price-to-Operating-Cash-Flow Chart

Catalent Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.32 42.45 43.51 30.91 37.97

Catalent Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.23 47.85 41.54 37.97 27.56

Competitive Comparison of Catalent's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Catalent's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Catalent's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Catalent's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Catalent's Price-to-Operating-Cash-Flow falls into.


;
;

Catalent Price-to-Operating-Cash-Flow Calculation

Catalent's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=63.48/2.198
=28.88

Catalent's Share Price of today is $63.48.
Catalent's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.20.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Catalent Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Catalent's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Catalent Business Description

Traded in Other Exchanges
N/A
Address
14 Schoolhouse Road, Somerset, NJ, USA, 08873
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
Executives
Michelle R Ryan director 214 PARK BLVD S, VENICE FL 34285
Joseph Anthony Ferraro officer: SVP, General Counsel, CCO 56 EMILY ROAD, FAR HILLS FL 07931
David Mcerlane officer: Group President, Biologics C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Ricky Hopson officer: VP, Chief Accounting Officer CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Lisa Evoli officer: SVP, Chief HR Officer 311 ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Aristippos Gennadios officer: See Remarks C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Scott Gunther officer: See Remarks C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Alessandro Maselli officer: See remarks C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Matti Masanovich officer: SVP, Chief Financial Officer COLLINS & AIKMAN CORPORATION, 250 STEPHENSON HIGHWAY, TROY MI 48083
Steven Barg director ELLIOTT MANAGEMENT CORPORATION, 40 WEST 57TH STREET, NEW YORK NY 10019
John J Greisch director C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Frank A Damelio director C/O PFIZER INC., 235 EAST 42ND ST., NEW YORK NY 10017
Stephanie Okey director C/O ALBIREO PHARMA, INC., 10 POST OFFICE SQUARE, SUITE 502 SOUTH, BOSTON MA 02109
Jonathan Arnold officer: President, Oral Drug Delivery C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Steven L Fasman officer: See Remarks C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873